Year-over-year earnings per share growth for the last twelve months: ProPhase Labs, Inc. (PRPH)
ProPhase Labs, Inc. (PRPH) integrates laboratory diagnostics with the production of health products to create a comprehensive wellness brand. This quarterly EPS chart confirms the current trend, where the metric value stands at 48.60. Growth relies on expanding the clinic network and automating tests, although the company is overcoming a post-pandemic revenue decline by pivoting toward contract genomics under market pressure.
Analytical breakdowns for ProPhase Labs, Inc.
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Debt to Equity ProPhase Labs, Inc.|PRPH - Long-Term Liabilities to Capital|Short-Term Debt to Equity ProPhase Labs, Inc.|PRPH - Company Aggregate Indebtedness|Debts to Book Capitalization ProPhase|PRPH - Company Long-Term Loans and Borrowings|Company Short-Term Debts ProPhase Labs|Quick Liquidity prophaselabs.com
- earnings and market multiples details:
PRPH - Net Financial Result|Projected Future Earnings ProPhase Labs, Inc.|PRPH - Market Cap to Earnings|Projected Price to Earnings ProPhase|PRPH - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ProPhase|PRPH - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) ProPhase Labs|PRPH - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth prophaselabs.com|PRPH - Earnings per share growth in current year|Net earnings per share growth forecast for next year ProPhase Labs, Inc.
General company analysis:ProPhase Labs - PRPH
Quarterly EPS growth measures the dynamics of net income per share, allowing investors to assess capital generation efficiency and business scaling rates. By analyzing the quarterly EPS trajectory, one can determine how successfully ProPhase Labs, Inc. (PRPH) is transitioning from stagnating core tests to high-margin genomics and early cancer diagnostics segments to protect asset value.
Who ProPhase Labs, Inc. competes with
A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity, Inc. (RVTY)|BIO: Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Anbio NNNN|Year-over-year earnings per one share growth for the last 12 months SHC|QDEL - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months OPKO Health Corp.|caredx.com (CDNA) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months MRVI (maravai.com)|FLGT (Fulgent Genetics) - Quarterly EPS earnings growth|LAB: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CTKB|Quarterly EPS earnings growth OraSure Corp (OSUR)|Year-over-year earnings per share growth for the last twelve months Exagen XGN|Year-over-year net earnings per share change for the last twelve months mdxhealth.com (MDXH)|Lucid Diagnostics - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Prenetics Global|IMDX (imdxinc.com) - Year-over-year net earnings per share growth for the last 12 months|Trinity Biotech - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Ainos, Inc.|Year-over-year earnings per share growth for the last twelve months CODX|Quarterly EPS earnings growth HSCS|Quarterly EPS earnings growth Biomerica Inc. (BMRA)|Quarterly EPS earnings growth CDIO (Cardio Diagnostics Holdings)|Onconetix Corporation - Year-over-year earnings per share growth for the last twelve months|VRAX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months bluejaydx.com BJDX|AWH (Aspira Women's Health Inc.) - Year-over-year net earnings per share growth for the last 12 months|Accelerate Diagnostics Inc. - Year-over-year earnings per one share growth for the last 12 months|CNTG (CENTOGENE) - Quarterly EPS earnings growth|Enzo (ENZ) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Fresh2 Group Limited (FRES)|gtglabs.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth ME (23andMe)|PMD - Year-over-year net earnings per share growth for the last 12 months
